We are thrilled to announce that this week, our esteemed partner Lion TCR has achieved IND approval from China’s NMPA
On July 29, 2024, Porton Advanced Solutions (“Porton Advanced”) announced that it had reached a strategic cooperation with Guangzhou Geneseed
Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell engineering platform, marking the company
On September 13th, 2023, Porton Advanced Solutions (Porton Advanced) announced a strategic partnership with BRL Medicine Inc. (BRL Medicine).
SUZHOU, China, March 13, 2023 /PRNewswire/ — On March 7th, 2023, Suzhou Porton Advanced Solutions Ltd. (Porton Advanced) and Bennu Biotherapeutics (Bennubio) announced a
SUZHOU,China, March 2, 2023 /PRNewswire/ — Porton Advanced Solutions Ltd. (Porton Advanced) and DanausGT Biotechnology Co., Ltd. (DanausGT) announced on February 27, 2023,
SUZHOU, China, Feb. 24, 2023 /PRNewswire/ — On February 20, 2023, Porton Advanced Solutions Ltd. (Porton Advanced) and Yinjia (Shanghai) Biosciences Co., Ltd. (Yinjia
On May 31, 2021, Porton Biologics Ltd. (hereinafter referred to as Portonbio) announced a strategic cooperation with Nanjing KAEDI Biotech,
22 April 2022 – Suzhou Porton Advanced Solutions Ltd. (‘Porton Advanced’) and Guizhou Sinorda Biomedicine Co. Ltd (‘Sinorda Biomedicine’) today
On April 16, 2021, Suzhou Porton Biologics Ltd.(hereinafter referred to as Porton Biologics), a subsidiary of Porton Pharma Solutions Ltd.
